Human Reproduction, Vol. 11, No. suppl_4, pp. 1-26, 1996
© 1996 European Society of Human Reproduction and Embryology
Cytogenetics of infertile men
1 Centre for Medical Genetics Laarbeeklaan 101, B-1090 Brussels, Belgium 2 Centre for Reproductive Medicine, University Hospital, Dutch-speaking Free University of Brussels (Vrije Universiteit Brussel) Laarbeeklaan 101, B-1090 Brussels, Belgium
Correspondence: 3To whom correspondence should be addressed
Chromosomally derived sterility has long been recognized. A review of the literature of somatic chromosome investigations in infertile males has shown that 13.7% of azoospermic males and 4.6% of oligozoospermic males have an abnormal karyotype. In the first group, sex chromosome abnormalities predominate (mainly 47, XXY), whereas in the latter, autosome anomalies (i.e. Robertsonian and reciprocal translocations) are the most frequent. A similar review on meiotic studies revealed that meiotic chromosome anomalies can explain male infertility in 4.3–40.4% of patients. Recently, fluorescent in-situ hybridization studies on spermatozoa from infertile men were published; it was suggested that both X–Y pairing and pairing of the autosomes were impaired, resulting in spermatogenic disruption. We investigated cytogenetically 694 infertile men with abnormal sperm parameters. More patients are needed for this research to investigate the relationship, if any, between the type of chromosome abnormality and its influence on the number, morphology and motility of spermatozoa. To be able to provide proper counselling for those couples whose male infertility can now be treated by intracytoplasmic sperm injection, it is suggested that clinical investigations should include mitotic and meiotic studies, an analysis of the chromosome content of individual spermatozoa and a DNA analysis of blood and spermatozoa to detect partially deleted Y chromosome material.
Key words: chromosome aberration/infertility/meiosis/spermatogenesis